5897 V Pill: white, round, 12mm
The pill with imprint 5897 V (White, Round, 12mm) has been identified as Sulfamethoxazole and Trimethoprim 400 mg / 80 mg and is used for Bacterial Skin Infection, Bacterial Infection, Diverticulitis, Bronchitis, and Epiglottitis. It belongs to the drug class sulfonamides and is not a controlled substance.
Images for 5897 V
Sulfamethoxazole and Trimethoprim
- Imprint
- 5897 V
- Strength
- 400 mg / 80 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Sulfonamides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Qualitest Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00603-5780 (Discontinued)
- Inactive Ingredients
-
docusate sodium,
magnesium stearate,
povidone,
corn starch,
sodium benzoate,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
See also:
More about sulfamethoxazole / trimethoprim
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,726)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: sulfonamides
- En español
Patient resources
- Sulfamethoxazole and trimethoprim drug information
- Sulfamethoxazole/trimethoprim (Advanced Reading)
- Sulfamethoxazole and Trimethoprim Injection
- Sulfamethoxazole and Trimethoprim Tablets
- Sulfamethoxazole and Trimethoprim Suspension
Other brands
Bactrim, SMZ-TMP DS, Septra, Septra DS, ... +3 more
Professional resources
- Sulfamethoxazole Trimethoprim Oral Suspension prescribing information
- Sulfamethoxazole and Trimethoprim (FDA)
- Sulfamethoxazole and Trimethoprim Concentrate Injection (FDA)
- Sulfamethoxazole and Trimethoprim Double Strength (FDA)
- Sulfamethoxazole and Trimethoprim Injection (FDA)
- Sulfamethoxazole and Trimethoprim Suspension (FDA)
Other brands
Bactrim, Septra, Co-trimoxazole, Sulfatrim
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.